Iris B. Parr

537 total citations
17 papers, 441 citations indexed

About

Iris B. Parr is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Iris B. Parr has authored 17 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Iris B. Parr's work include Estrogen and related hormone effects (6 papers), Cancer Research and Treatments (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Iris B. Parr is often cited by papers focused on Estrogen and related hormone effects (6 papers), Cancer Research and Treatments (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Iris B. Parr collaborates with scholars based in United Kingdom and Belgium. Iris B. Parr's co-authors include Peter Alexander, Raymond McCague, Michael Jarman, K. E. K. Rowson, Martin Rowlands, Phyllis M. Goddard, Benjamin P. Haynes, Guy Leclercq, John Mann and A. B. Foster and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Journal of Medicinal Chemistry and British Journal of Cancer.

In The Last Decade

Iris B. Parr

17 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iris B. Parr United Kingdom	9	160	152	142	117	43	17	441
Elliott H. Stonehill United States	8	72 0.5×	192 1.3×	61 0.4×	110 0.9×	29 0.7×	12	408
I Cerutti France	13	54 0.3×	201 1.3×	112 0.8×	77 0.7×	18 0.4×	36	476
Barry W. Duceman United States	13	232 1.4×	343 2.3×	127 0.9×	42 0.4×	32 0.7×	22	599
Erling M. Jensen United States	8	243 1.5×	202 1.3×	62 0.4×	130 1.1×	17 0.4×	10	525
Earl M. Ritzi United States	11	139 0.9×	151 1.0×	71 0.5×	147 1.3×	10 0.2×	24	421
Lionel A. Manson United States	15	89 0.6×	434 2.9×	219 1.5×	100 0.9×	44 1.0×	57	795
Geoffrey H. Sunshine United States	17	63 0.4×	280 1.8×	694 4.9×	96 0.8×	42 1.0×	36	1.1k
R. James Brawn United States	8	135 0.8×	152 1.0×	166 1.2×	83 0.7×	14 0.3×	10	397
S. Yoshida Japan	17	82 0.5×	487 3.2×	58 0.4×	137 1.2×	15 0.3×	39	749
Carrie E. Whitmire United States	13	104 0.7×	206 1.4×	79 0.6×	88 0.8×	10 0.2×	27	535

Countries citing papers authored by Iris B. Parr

Since Specialization

Citations

This map shows the geographic impact of Iris B. Parr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris B. Parr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris B. Parr more than expected).

Fields of papers citing papers by Iris B. Parr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris B. Parr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris B. Parr. The network helps show where Iris B. Parr may publish in the future.

Co-authorship network of co-authors of Iris B. Parr

This figure shows the co-authorship network connecting the top 25 collaborators of Iris B. Parr. A scholar is included among the top collaborators of Iris B. Parr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris B. Parr. Iris B. Parr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Hardcastle, Ian R., Martin Rowlands, Iris B. Parr, et al.. (1995). Rationally Designed Analogs of Tamoxifen with Improved Calmodulin Antagonism. Journal of Medicinal Chemistry. 38(2). 241–248. 33 indexed citations

McCague, Raymond, Iris B. Parr, & Benjamin P. Haynes. (1990). Metabolism of the 4-iodo derivative of tamoxifen by isolated rat hepatocytes. Biochemical Pharmacology. 40(10). 2277–2283. 29 indexed citations

Rowlands, Martin, Iris B. Parr, Raymond McCague, Michael Jarman, & Phyllis M. Goddard. (1990). Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; Correlations with cytotoxicity. Biochemical Pharmacology. 40(2). 283–289. 70 indexed citations

McCague, Raymond, et al.. (1990). Metabolism of tamoxifen by isolated rat hepatocytes. Biochemical Pharmacology. 39(9). 1459–1465. 26 indexed citations

Parr, Iris B., Martin Rowlands, John Houghton, & Michael Jarman. (1988). Inhibition of the formation of 4-hydroxyandrostenedione glucuronide by valproate. Biochemical Pharmacology. 37(23). 4581–4583. 3 indexed citations

Parr, Iris B., et al.. (1987). Metabolism of tamoxifen by isolated rat hepatocytes. Biochemical Pharmacology. 36(9). 1513–1519. 11 indexed citations

Foster, A. B., Michael Jarman, John Mann, & Iris B. Parr. (1986). Metabolism of 4-hydroxyandrost-4-ene-3,17-dione by rat hepatocytes. Journal of Steroid Biochemistry. 24(2). 607–617. 20 indexed citations

Parr, Iris B., L. Elizabeth Jackson, & Peter Alexander. (1983). Role of “lymphotoxin” in the local anti-tumour action associated with inflammation caused by delayed hypersensitivity responses or intralesional BCG. I. Variations in response of different syngeneic mouse tumours. British Journal of Cancer. 48(3). 395–403. 4 indexed citations

Alexander, Peter, Iris B. Parr, & L. Elizabeth Jackson. (1981). Mechanism of the local antitumor action of inflammation.. PubMed. 13(4). 1929–31. 2 indexed citations

10.

Parr, Iris B., et al.. (1977). Selective Mobilization of Specifically Cytotoxic T-Lymphocytes at Sites of Inflammation in Relation to BCG-Induced Resistance to Implants of Syngeneic Sarcoma in Mice 2. JNCI Journal of the National Cancer Institute. 59(6). 1659–1666. 6 indexed citations

11.

Parr, Iris B.. (1976). BCG and the specific immune response to tumor. Cancer Immunology Immunotherapy. 1-1(1-2). 6 indexed citations

12.

Parr, Iris B., et al.. (1975). Rejection of sarcoma cells at the site of an inflammatory reaction: Macrophages are not the only effector cells. Cancer Letters. 1(1). 49–53. 6 indexed citations

13.

Parr, Iris B.. (1974). Demonstration of the antitumour effect of in vivo macrophage activation. British Journal of Cancer. 30(2). 182–182. 2 indexed citations

14.

Parr, Iris B., et al.. (1973). Similarities of the Anti-tumour Actions of Endotoxin, Lipid A and Double-stranded RNA. British Journal of Cancer. 27(5). 370–389. 103 indexed citations

15.

Parr, Iris B.. (1972). Response of Syngeneic Murine Lymphomata to Immunotherapy in Relation to the Antigenicity of the Tumour. British Journal of Cancer. 26(3). 174–182. 79 indexed citations

16.

Rowson, K. E. K. & Iris B. Parr. (1970). A new virus of minimal pathogenicity associated with friend virus. I. Isolation by end‐point dilution. International Journal of Cancer. 5(1). 96–102. 38 indexed citations

17.

Rowson, K. E. K., Iris B. Parr, & Tikvah Alper. (1968). Radiation target size of Riley virus. Virology. 36(1). 157–159. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact